LeMaitre Vascular reported Q4 2021 financial results, with sales increasing by 5% to $39.5 million. Operating income decreased by 13% to $8.3 million, while net income decreased by 12% to $6.2 million. The company announced a quarterly dividend of $0.125/share, a 14% increase, and provided forward guidance.
Sales increased by 5% to $39.5 million, with 6% organic growth compared to Q4 2020.
Operating income decreased by 13% to $8.3 million, resulting in an operating margin of 21%.
Net income decreased by 12% to $6.2 million, with earnings of $0.28 per diluted share, an 18% decrease.
Cash and investments increased by $2.9 million to $70.0 million.
The company provided sales guidance for the next quarter and full year 2022. They anticipate sales between $37.7 million and $39.7 million for the next quarter and between $162 million and $166 million for the full year.
Analyze how earnings announcements historically affect stock price performance